SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001136261-23-000033 from Cardio Diagnostics Holdings, Inc. (CDIO)

Cardio Diagnostics Holdings, Inc.
Date: Jan. 20, 2023 · CIK: 0001870144 · Accession: 0001136261-23-000033

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-268759

Date
January 20, 2023
Author
Elisa Luqman
Form
CORRESP
Company
Cardio Diagnostics Holdings, Inc.

Letter

Cardio Diagnostics Holdings, Inc.

400 North Aberdeen Street, Suite 900

Chicago, IL 60642

January 20, 2023

VIA EDGAR

Division of Corporation Finance

Office of Life Sciences

U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attn: Cindy Polynice

Jason Drory

Re: Cardio Diagnostics Holdings, Inc.

Registration Statement on Form S-1

File No. 333-268759

Acceleration Request

Requested Date: January 24, 2023

Requested Time: 4:30 p.m. Eastern Time, or as soon thereafter as practicable

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cardio Diagnostics Holdings, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-268759) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Shartsis Friese LLP, by calling Rupert Russell at (415) 425-5839.

Please direct any questions or comments regarding this acceleration request to Mr. Russell at the above-telephone number. Thank you.

[Signature page follows]

Very truly yours,
CARDIO DIAGNOSTICS HOLDINGS, INC.

Show Raw Text
CORRESP
1
filename1.htm

Cardio Diagnostics Holdings, Inc.

400 North Aberdeen Street, Suite 900

Chicago, IL 60642

January 20, 2023

VIA EDGAR

Division of Corporation Finance

Office of Life Sciences

U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attn:      Cindy Polynice

Jason Drory

Re:	Cardio Diagnostics Holdings, Inc.

Registration Statement on Form S-1

File No. 333-268759

Acceleration Request

	Requested Date:     	January 24, 2023

	Requested Time:	    4:30 p.m. Eastern Time, or as soon thereafter
as practicable

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Cardio Diagnostics Holdings, Inc. (the “Company”) hereby requests that the above-referenced
Registration Statement on Form S-l (File No. 333-268759) (the “Registration
Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at
such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation
Finance of the Securities and Exchange Commission.

Once the Registration Statement has been declared
effective, please orally confirm that event with our counsel, Shartsis Friese LLP, by calling Rupert Russell at (415) 425-5839.

Please direct any questions or comments regarding
this acceleration request to Mr. Russell at the above-telephone number. Thank you.

[Signature page follows]

Very truly yours,

CARDIO DIAGNOSTICS HOLDINGS, INC.

By:		/s/ Elisa Luqman

Elisa Luqman

Chief Financial Officer

cc:       Meeshanthini Dogan, Ph.D.

Chief Executive Officer

P. Rupert Russell, Esq.

Shartsis Friese LLP